Tweet
Hi !
Is anybody using ABI's SOLiD 3 SAGE kit, and in particular, running SOLiD SAGE Analysis Software version 1.06 ?
Is anybody using ABI's SOLiD 3 SAGE kit, and in particular, running SOLiD SAGE Analysis Software version 1.06 ?
-
-
Hi,
I did not know that also ABI sells such a kit. I thought it is from Invitrogen. Am I wrong?
All the best
Peter -
Hi, Peter
I don't know about the vender; you might be right there.
The SAGE guidebook I am using is mentioning AB and Invitrogen.
Thank you for your information.
Regards!Comment
-
Life Tech has bought Invitrogen. The SAGE kit is originally from Invitrogen but now carries an ABI branding. We will be using the SAGE kit in the near future, and most probably will be using the SAGE software from solidsoftwaretools.com.Comment
-
That's great. So, the ABI SAGE community gets little by little bigger...
Please let me know your experiences! Thank you and best regards!Comment
-
Hey guys, how did you end up with SOLiD SAGE? I'm working with Human Genome, and I have the feeling that the program is not functioning well, esp. that it's sooo slow! Did you guys find some alternative programs?Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment